RUNX1突变减轻静息状态促进范可尼贫血中造血祖细胞的转化
研究利用人诱导多能干细胞对MDS相关基因突变热点进行多重基因编辑并诱导造血分化,发现携带RUNX1插入缺失的造血干祖细胞异常自我更新且分化受损,RUNX1突变通过削弱G1/S细胞周期检查点并激活先天免疫信号稳定BRCA1,该通路可作为范可尼贫血相关MDS的治疗靶点。
要点
- RUNX1插入缺失在FA背景下富集,导致HSPC异常自我更新和分化受损。
- 与失败状态相比,FA MDS细胞中突变RUNX1削弱DNA损伤激活的G1/S检查点。
- RUNX1插入缺失激活先天免疫信号稳定BRCA1,靶向该通路可降低FA MDS细胞活力并恢复对基因毒物的敏感性。
核心结论
- 研究建立了IBMFS克隆演化模型,增进了对MDS发病机制的理解,并揭示了FA相关MDS的治疗靶点。
研究设计与样本
- 在人诱导多能干细胞中对MDS相关基因突变热点进行多重基因编辑,随后进行造血分化。
主要发现
- 携带RUNX1插入缺失的造血干祖细胞显示异常自我更新和分化受损。
- 与失败状态相比,FA MDS细胞显示突变RUNX1介导的G1/S细胞周期检查点削弱。
- RUNX1插入缺失激活先天免疫信号,稳定同源重组效应因子BRCA1。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many inherited bone marrow failure syndromes (IBMFSs) present a high risk of transformation to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). During transformation of IBMFSs, hematopoietic stem and progenitor cells (HSPCs) with poor fitness gain ectopic, dysregulated self-renewal secondary to somatic mutations via undefined mechanisms. Here, in the context of the prototypical IBMFS Fanconi anemia (FA), we performed multiplexed gene editing of mutational hotspots in MDS-associated genes in human induced pluripotent stem cells (iPSCs) followed by hematopoietic differentiation. We observed aberrant self-renewal and impaired differentiation of HSPCs with enrichment of RUNX1 insertions and deletions (indels), generating a model of IBMFS-associated MDS. We observed that compared to the failure state, FA MDS cells show mutant RUNX1-mediated blunting of the G1/S cell cycle checkpoint that is normally activated in FA in response to DNA damage. RUNX1 indels also lead to activation of innate immune signaling, which stabilizes the homologous recombination (HR) effector BRCA1, and this pathway can be targeted to abrogate viability and restore sensitivity to genotoxins in FA MDS. Together, these studies develop a paradigm for modeling clonal evolution in IBMFSs, provide basic understanding of the pathogenesis of MDS, and uncover a therapeutic target in FA-associated MDS.
引用
- Marion W, Koppe T, Chen CC, et al. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia. Leukemia. 2023. PMID: 37391485. doi:10.1038/s41375-023-01945-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。